Meeting
2020 Genitourinary Cancers Symposium
Defining the genetic evolution of epigenetic alterations in bladder cancer.
Authors
Timothy Nguyen Clinton
Memorial Sloan-Kettering Cancer Center - Fellowship (GME Office), New York, NY
Timothy Nguyen Clinton , Hannah Wise , Nima Almassi , Shweta S. Chavan , Wenhuo Hu , Sizhi Paul Gao , Aphrothiti Hanrahan , Shawn Dason , Eugene J. Pietzak , Maria Isabel Carlo , Samuel Aaron Funt , Min Yuen Teo , Gopa Iyer , Bernard H. Bochner , Jonathan E. Rosenberg , Dean F. Bajorin , Maria E. Arcila , Hikmat Al-Ahmadie , Barry S. Taylor , David B. Solit
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 529)
Abstract #
529
Poster Bd #
K10
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Non-urothelial bladder cancer: Genomic alterations and patient outcomes.
First Author: Fern Anari
Poster
2014 ASCO Annual Meeting
Comprehensive molecular profiling of urothelial bladder cancer at the DNA, RNA, and protein levels: A TCGA project.
First Author: John N. Weinstein
First Author: Panagiotis J. Vlachostergios
Poster
2014 Genitourinary Cancers Symposium
Using exon-capture, deep sequencing of high-grade bladder urothelial carcinoma to identify recurrent genetic alterations and potential therapeutic targets.
First Author: Philip H. Kim